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Background: In the less-sensitive mouse model, Shiga toxin-producing Escherichia coli (STEC) challenges result in
shedding that reflect the amount of infection and the expression of virulence factors such as Shiga toxins (Stx). The
purpose of this study was to characterize the contribution of STEC diversity and Stx expression to shedding in beef
feeder calves and to evaluate the effectiveness of a prebiotic, CelmanaxW, to alleviate STEC shedding. Fecal samples
were collected from calves at entry and after 35 days in the feedlot in spring and summer. STECs were evaluated
using selective media, biochemical profile, serotyping and Stx detection. Statistical analysis was performed using
repeated measures ANOVA and logistic regression.
Results: At entry, non-O157 STEC were dominant in shedding calves. In spring, 21%, 14% and 14% of calves
acquired O157, non-O157 and mixed STEC infections, respectively. In contrast, 45%, 48% and 46% of calves in
summer acquired O157, non-O157 and mixed STEC infections, respectively. Treatment with a prebiotic, CelmanaxW,
in spring significantly reduced 50% of the O157 STEC infections, 50% of the non-O157 STEC infections and 36% of
the STEC co-infections (P = 0.037). In summer, there was no significant effect of the prebiotic on STEC infections.
The amount of shedding at entry was significantly related to the number and type of STECs present and Stx
expression (r2 = 0.82). The same relationship was found for shedding at day 35 (r2 = 0.85), but it was also related to
the number and type of STECs present at entry. Stx - producing STEC infections resulted in 100 to 1000 × higher
shedding in calves compared with Stx-negative STECs.
Conclusions: STEC infections in beef feeder calves reflect the number and type of STECs involved in the infection
and STEC expression of Stx. Application of CelmanaxW reduced O157 and non-O157 STEC shedding by calves but
further research is required to determine appropriate dosages to manage STEC infections.
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Both O157 and non-O157 STECs are bacteria that cause
serious human disease outbreaks through the consump-
tion of contaminated food products [1]. Historically, STEC
infections were not linked with the development of disease
in older calves or mature cattle [2,3], leading to the con-
clusion that these bacteria are part of the normal gut flora.
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reproduction in any medium, provided the ortransmission to foods were developed based upon the
premise that STECs were not pathogens including altering
the normal flora using direct-fed microbial feed additives
[4] and procedural changes at slaughter [5]. Recent studies
indicate that STEC co-infections and mycotoxins are part
of the disease complex for Jejunal Hemorrhage Syndrome
(JHS) in beef feeder calves and mature dairy cattle [6,7]
supporting an interaction between the host and pathogen
that leads to infection. Several other studies provide indir-
ect evidence that supports the hypothesis that STECs
interact with the intestinal tract of older age classes ofral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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fections in beef feeder calves and mature cattle resemble
those described in another less sensitive STEC disease
model, the mouse, and include discolored feces, hind-limb
paralysis, tremors, ataxia and death [8-10]. Persistent shed-
ding in beef cattle is associated with repeated isolations of
challenge STEC from experimental cattle [11] and repeated
isolations of STEC clones from natural infections in the
feedlot [12]. Stx is associated with STEC infection in chal-
lenge studies with immature calves [13-15] and Stx2 in-
creases STEC colonization of enterocytes isolated from
mature cattle in vitro [16] while, Stx1 is toxic to particular
classes of lymphocytes in immature calves [15]. If we are to
improve on current methods to reduce food safety con-
cerns associated with STEC transmission to foods, it is es-
sential that we examine STEC pathogenesis in older calves
and mature cattle. For example, what role if any do Stxs
play in promoting infections and shedding [17], are other
pathogens present [18] and what is the nature of the infec-
tions in different shedding categories [19]. Using the mouse
model as a guide, shedding patterns and susceptibility to
disease are related to STEC virulence traits with the major-
ity of avirulent strains producing transient infection and
shedding with no symptoms [8-10]. As antibiotics are con-
traindicated for STEC infections in humans [20] and pre-
biotic/probiotic applications alleviate the clinical symptoms
and the development of acute STEC-associated disease in
cattle [6,7], a similar approach could address food safety
concerns. The first objective of the current study was to
characterize STEC pathogenesis in beef feeder calves with
respect to the source of the infections, the type of STECs
involved and the role of Stxs. The second objective was to
determine the impact of a prebiotic, CelmanaxW, applica-
tion on STEC infections and shedding in beef feeder calves.
Methods
The protocols were reviewed by the Agriculture and Agri-
Food Canada Animal Care Committee and approved under
ACC protocol 1131. This study had two main objectives,
first to characterize STEC infections in beef feeder calves
and second, to determine the impact of a prebiotic on
STEC shedding.
Experimental animals
Two groups of heifers were used in the study: LOAD 1 with
56 animals and an average body weight of 193 kg; and
LOAD 2 with 63 animals and an average body weight of
189 kg. The animals arrived in Texas on May 5, 2011 and
June 16, 2011 respectively and the heifers were randomly
assigned to treatments. The receiving diet consisted of
0.9 kg/heifer of ryegrass hay and water with or without the
treatment, CelmanaxW (14 g/[heifer•d]. The heifers were
processed and assigned to one of 12 pens. The heifers were
provided either a control diet consisting of 65% concentratewith the major ingredients steam-flaked corn, alfalfa
hay, cottonseed hulls, cottonseed meal, molasses, and
animal-vegetable fat or the same diet supplemented with
CelmanaxW (14 g/[heifer•d]. The CelmanaxW consists of a
non-living formulation of yeast cell walls or mannan oligo-
saccharide (MOS) and yeast metabolites. This product has
been shown to antagonize O157 and non-O157 STEC
colonization and eliminate feed-associated mycotoxin
cytotoxicity in vitro [6,7]. To evaluate STEC infections in
the calves, fecal ESWAB samples (Alere™, Ottawa, Ontario
Canada) were collected during the weighing process on
day 0 and day 35.
STEC characterization
Fecal samples from the control and treatment heifers were
evaluated for O157 and non-O157 STECs using a method
that was developed previously [6,7]. Fecal samples were
weighed (0.01 g per swab) and all samples were glycerol
stocked (20%) and stored at –20°C or serial dilutions were
applied to CHROMagar™ O157 plates (Dalynn Biologicals,
Calgary, Alberta). Using this approach, STECs are isolated
from CHROMagar™ O157 with O157 STEC appearing as
mauve colonies and non-O157 STEC appearing as mauve
colonies or blue colonies with a mauve halo. To confirm
identity, the presumptive isolates were subjected to a GN-
ID A + B biochemical test (Alere™, Ottawa, Ontario,
Canada). To distinguish potential O157 STECs from non-
O157 STECs, bacteria were plated onto Cefixime-Tellurite
Sorbitol MacConkey agar (CT-SMAC; Dalynn Biologicals,
Calgary, Alberta, Canada) to identify non-sorbitol and sorb-
itol fermenting bacterial colonies. All suspect colonies were
tested as O157 and H7 using the RIM™ E. coli O157 latex
test (Fisher Scientific, Ottawa, Ontario, Canada). To further
characterize the composition of STEC infections, presump-
tive STECs were also tested using the Remel Polyvalent 2
(O26, O55, O111, O119, O126) sera, Remel Polyvalent 3
(O83, O114, O125, O127, O128) sera and Remel Polyvalent
4 (O44, O112, O124, O142) sera (Oxoid, Nepean,
Ontario, Canada). Because O26 and O111 STEC infections
are on the rise in human disease outbreaks, all STECs posi-
tive for polyvalent 2 were subsequently tested using Denka-
Seiken O26 and O111 monovalent sera (Oxoid, Nepean,
Ontario, Canada). All bacterial colonies that were identified
as E. coli in the GN-ID A + B test were characterized for
Stx1 and Stx2 expression using an ImmunoCard STAT!W
EHEC test (Somagen, Edmonton, Alberta, Canada) [6,7].
The statistical analysis was performed using isolates
that were biochemically defined as E. coli and identified
to serotype.
Statistical analysis
Statistical analyses were conducted utilizing Repeated Mea-
sures ANOVA for evaluating the impact of the prebiotic
on STEC shedding (SYSTAT 10.2.01). The statistical model
Table 1 Prevalence of O157 and non-O157 STECs in beef
feeder calves in spring and summer
Percent O157 STEC Percent Non-O157 STEC
Season Day 0 Day 35 Day 0 Day 35
Spring (n = 56) 7 27 36 77
Summer(n = 61) 11 87 40 72
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it + eijt: yijt is the measurement taken at time t on the jth
calf assigned to the ith diet treatment, yo is a covariate
(pre-treatment measurement), μ is the overall mean effect,
di is the ith fixed diet effect, γj(i) is the random effect of
the jth calf within ith diet treatment, τt is the fixed time ef-
fect when the measurement was taken, (dτ) it is the fixed
interaction effect between diet and time, eijt is the random
error associated with the jth calf assigned to the ith diet
treatment at time t.
Analysis was also performed using multinomial logistic
regression to evaluate the contribution of STEC identity,
the number of STECs present and Stx expression on in-
fection as evidenced by shedding at entry and after
35 days in the feedlot.
Results were considered significant if P < 0.05 and
non-significant if P > 0.05.
Results
Randomizing calves to treatments
Randomizing the calves to pens did not result in an even
distribution of STEC-shedding calves to treatments. The
control treatments for spring had 76% non-shedding calves
and 24% shedding calves. In contrast, the prebiotic treat-
ments for spring had 61% non-shedding calves and 39%
shedding calves. Similarly, the control treatments for sum-
mer had 64% non-shedding calves and 36% shedding calves.
In contrast, the prebiotic treatments for summer had 46%
non-shedding calves and 54% shedding calves. More critic-
ally, there was a higher percentage of moderate to high
shedding calves at entry in spring and summer in the
CelmanaxW treatment (spring, 32%; summer 19%) com-
pared with the control treatment (spring, 11%; summer,
10%). The results from the current study suggest that these
imbalances could influence the evaluation of the effective-
ness of the treatment and thus, more effort must be taken
at entry to balance the shedding calves across treatments.
STEC identification
The method used in the current study is a novel ap-
proach for detecting STECs in calves thereby, an ex-
planation of the STEC morphologies and other false
positive pathogenic Enterobacteriaceae are provided.
Non-STEC pathogens appeared as large mauve col-
onies with a white halo and an irregular edge or yellow
regular smooth colonies with a regular edge. These iso-
lates were confirmed as pathogenic bacteria in the GN-
ID A + B test. Less than 5% of the animals in the study
were co-infected with Citrobacter species and E. fergusonii,
but these animals were associated with low STEC shedding
rates (<102 CFU/0.01 g feces) and were not detected in the
35 day sample. This suggests that co-infection with other
Enterobacteriaceae does not contribute to STEC infections
in beef feeder calves.Presumptive STECs had two phenotypes on CHRO-
Magar™ O157 plates: mauve colonies with a white halo that
had a regular or irregular edge (O157 STEC and non-O157
STEC); and navy blue colonies with a mauve halo (non-
O157 STEC) that had a regular or irregular edge. There was
a high degree of variation in the blue colonies with mauve
halos that distinguished one non-O157 STEC from another.
Presumptive STECs were confirmed as pathogenic E. coli in
the GN-ID A + B test, serotyped and the Stx expression pro-
file determined. At entry to the feedlot in spring, 70 poten-
tial STECs were isolated and 24 STECs were confirmed
(Table 1). The false positive isolates were collected at 48 hr
suggesting that evaluations performed after 24 hr are invalid.
After 35 days in the feedlot, 93 potential STECs were iso-
lated and 58 STECs were confirmed (Table 1). At entry to
the feedlot in summer, 70 potential STECs were isolated
and 32 STECs were confirmed. After 35 days in the feedlot,
120 potential STECs were isolated and 100 STECs were
confirmed (Table 1). The prevalence for O157 STEC shed-
ding by beef feedlot calves using this CHROMagar™ O157
detection method is within the range reported for beef
feeder calves in feedlot environments in the USA using PCR
and IMS – based methods [21,22]. In September 2011, the
Food Safety and Inspection Service in the USA declared 6
non-O157 STECs adulterants including serotypes O26,
O111, O103, O121, O145 and O45 [23]. The prevalence for
common non-O157 STEC serotypes in beef feeder calves
were determined in this study and are provided in Table 2.
These prevalence rates reflect those reported for beef feed-
lots in the USA using PCR and IMS – based detection sys-
tems [21,22]. There were 2 calves that had single isolate
infections with non-O157 STEC displaying the auto-
agglutinating adhesin described for LEE-negative STECs
[24]. One strain produced Stx1 and the other strain pro-
duced Stx2. After 35 days in the feedlot in spring, there
was an increase in the prevalence of O111 STEC, other
STEC within the polyvalent 2 sera group (O55, O119,
O126) and polyvalent 3 sera group (O83, O114, O125,
O127, O128). There were no increases in the O26 or poly-
valent 4 sera group (O44, O112, O124 and O142). After
35 days in the feedlot for summer, the same increase in
O111 STEC, polyvalent 2 sera group and polyvalent 3 sera
group was detected. However, there was a decline in 026
STEC shedding.
The current study together with previous studies
[6,7] suggest that the CHROMagar™ O157 method in
Table 2 Prevalence of non-O157 STEC serotypes shed by
beef feeder calves in spring and summer [polyvalent 2
sera (O26, O55, O111, O119, O126), polyvalent 3 sera
(O83, O114, O125, O127, O128), polyvalent 4 sera (O44,
O112, O124 and O142), monovalent O26 sera and
monovalent O111 sera]
Percent non-O157 STEC
Season P2 O26 O111 P3 P4
Spring day 0 3 17 17 3 7
Spring day 35 14 17 39 39 7
Summer day 0 6 19 12 0 6
Summer day 35 15 3 46 25 3
Figure 1 The average number of Shiga toxin – producing
Escherichia coli (STEC) shed by beef feeder calves fed diets
containing 0 (control) or 14 g/[heifer•d] Celmanax®. The fecal
samples were collected on day 0 and day 35. Mean values are
shown (n = 28 for both treatments in spring; n = 30 for control
treatments in summer; n = 31 for Celmanax® treatments in summer).
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effective in isolating O157 and non-O157 STECs shed
in the feces of calves in feedlots.
Seasonal STEC shedding
The average STEC shedding by calves was significantly
greater in summer compared with spring (Figure 1; P =
0.001). This change was associated with a higher percent-
age of calves shedding STEC at entry and day 35. For the
control treatment at entry, the percentage of calves shed-
ding STEC was 25% in spring and 36% in summer. For the
control treatment at day 35, the percentage of calves shed-
ding STEC was 64% in spring and 82% in summer. For the
CelmanaxW treatment at entry, the percentage of calves
shedding STEC was 39% in spring and 55% in summer.
For the CelmanaxW treatment at day 35, the percentage of
calves shedding STEC was 64% in spring and 93% in sum-
mer. The seasonal changes in shedding patterns for STEC
in the control calves indicated that most infections were
acquired in the feedlot (60-70%) while some infections
identified at entry (10%) were maintained over the 35 day
period. Interestingly, about 20% of the control calves did
not enter the feedlot with STEC infections or acquire in-
fections during the study period.
Seasonal O157 STEC, non-O157 STEC and mixed STEC
shedding
The composition of STEC infections significantly changed
over the 35 day period in the feedlot (P = 0.001, Figure 2).
The percentage of calves shedding STECs changed over the
experimental period and is an expression of maintained,
non-maintained or new STEC infections. In the control
treatment at entry in spring, O157 STEC infections were all
newly acquired and contributed to 21% of calves shedding
after 35 days. In contrast, non-O157 STEC infection (21%)
in calves at entry decreased to 14% due to non-maintained,
maintained or new infections after 35 days. Infections with
STEC mixtures consisting of O157 and non-O157 STEC
(7%) at entry increased to 14% due to maintained or
new infections after 35 days. In the control treatment insummer, O157 STEC infection (10%) in calves at entry
increased to 46% due to maintained or new infections
after 35 days. Similarly, non-O157 STEC infection (23%)
in calves at entry in summer increased to 27% due to
maintained or new infections after 35 days. Infections
with STEC mixtures (7%) in calves at entry in summer
increased to 35% due to maintained or new infections
after 35 days. These results indicate that stressor events
such as heat that occur in feedlots promote acquisition
and growth of STEC infections in calves.
In the CelmanaxW treatment in spring, O157 STEC in-
fection (14%) in calves at entry decreased to 7% due to
non-maintained or maintained infections after 35 days. In
contrast, non-O157 STEC infections (28%) in calves de-
creased to 14% due to non-maintained or maintained infec-
tions after 35 days. Infections with STEC mixtures (11%) in
calves at entry in spring decreased to 7% due to non-
maintained or maintained infections after 35 days. In the
CelmanaxW treatment in summer, O157 STEC infection
(13%) in calves at entry increased to 52% due to maintained
or new infections after 35 days. In contrast, non-O157
STEC infections (35%) in calves increased to 42% due to
maintained and new infections after 35 days. Infections with
STEC mixtures (6%) in calves in summer increased to 48%
due to maintained or new infections after 35 days.
The results suggest that the application of the
14 g/[heifer•d] of CelmanaxW reduced entry O157 STEC
Figure 2 The percentage change in the amount of Shiga toxin – producing Escherichia coli (STEC) shed between day 0 and day 35 by
beef feeder calves fed diets containing 0 (control) or 14 g/[heifer•d] Celmanax®. The fecal samples were collected at day 0 and day 35. Mean
values are shown (n = 28 for both treatments in spring; n = 30 for control treatments in summer; n = 31 for Celmanax® treatments in summer).
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in calves supporting previous in vitro studies which showed
anti-O157 STEC colonization properties for the prebiotic
[6,7]. Despite having a higher percentage of entry non-
O157 STEC infections in calves compared with control
treatments, the CelmanaxW also reduced entry non-O157
infections and the acquisition of new infections in calves
supporting previous in vitro studies which showed anti-
non-O157 STEC colonization properties for the prebiotic
[6,7]. Similarly, the CelmanaxW treatment reduced entry
STEC co-infections and the acquisition of new co-
infections in calves. This was recorded as a lower conver-
sion of either non-shedding calves to shedding calves or
low and moderate shedding calves to high shedding
calves. The results for summer were not significant, but
there was a similar trend as spring where the application
of the 14 g/[heifer•d] of CelmanaxW reduced O157 and
non-O157 STEC infections and the conversion of low
and moderate shedding calves to high shedding calves.STEC diversity and shedding by calves
Many experimental challenge studies have been performed
with beef feeder calves using inoculants containing one or
more O157 STEC [2,3,13,14]. However, these studies have
not examined whether other STEC infections already
present in the calves are contributing to the successful in-
fection with the challenge STEC. In the current study,
shedding at day 35 was predictable based on the number of
STECs involved in the infection (P = 0.001, Figure 3) which
indicated that co-infection increased the likelihood of shed-
ding by calves. The greater variability in the shedding at
day 35 for calves with two or more STECs involved in the
infection suggest that there may be an interaction betweenthese pathogens that dynamically changes as virulence fac-
tors are expressed.O157 STEC, Stx expression and shedding by calves
Shedding rates after 35 days in the feedlot occurred
when at least one O157 STEC was part of the infection
(P = 0.011, Figure 4). Interestingly, when there were
three or more O157 STECs present the shedding pat-
terns were lower and resembled non-O157 STEC infec-
tions. This suggested that the virulence traits for STECs
may potentially be driving successful infection and
shedding in calves rather than serotype. One virulence
trait that is critical for establishing STEC infections in
humans and mice is Stx production [1]. For example, a
challenge with Stx2 – producing strains is associated
with establishing high infections that result in the devel-
opment of clinical symptoms and disease in neonatal
calves [13,14] and mice [8-10]. Herein we describe a
similar feature where the expression of Stxs causes a
significant 100 to 1000 times greater infection as
evidenced by shedding when compared with STECs not
expressing Stxs (P = 0.001, Figure 5). Significantly, Stx2
– producing STEC infections consistently provided the
highest shedding in the calves and in this way resembles
results obtained with the less sensitive mouse model [1].Discussion
The current study demonstrates that beef feeder calves
show enhanced susceptibility to STEC infection and shed-
ding in response to Stx-producing strains as assessed by
fecal shedding. In addition, STEC mixtures and more spe-
cifically, those infections associated with O157 STECs
were required to elicit high shedding.
Figure 3 The effect of the number of Shiga toxin – producing
Escherichia coli (STEC) involved in an infection on the amount
of STEC shed by beef feeder calves fed diets containing 0
(control) or 14 g/[heifer•d] Celmanax®. The fecal samples were
collected at day 0 and again at day 35. Mean values are shown (n = 28
for both treatments in spring; n = 30 for control treatments in summer;
n = 31 for Celmanax® treatments in summer). The diversity of STECs
was scored as follows: 1 = one STEC in the fecal sample; 2 = two STEC
in the fecal sample, 3 =more than 2 STEC in the fecal sample).
Figure 4 The effect of the number of O157 Shiga toxin – producing
Escherichia coli (STEC) involved in an infection on the amount
of STEC shed by beef feeder calves fed diets containing 0
(control) or 14 g/[heifer•d] Celmanax®. The fecal samples were
collected at day 0 and day 35. Mean values are shown (n = 28 for
both treatments in spring; n = 30 for control treatments in summer;
n = 31 for Celmanax® treatments in summer). The contribution of
O157 STEC infections was scored as follows: 1 = one O157 STEC in
the fecal sample; 2 = two O157 STECs in the fecal sample, 3 = greater
than two O157 STECs in the fecal sample.
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performed using from one to four STECs with each pro-
ducing Stx1 and Stx2 [2,3,11,13,14]. The STECs used in
challenge studies for the most part originate from human
disease outbreaks rather than calf disease outbreaks. Over-
all, this approach may have contributed to our lack of un-
derstanding of how STEC virulence traits affect different
age classes of cattle. Mature cattle respond to STEC chal-
lenges with low, moderate and high shedding rates with
the magnitude and duration affected by age [2,3], expos-
ure dose [2] and a mucosal factor [25]. Typically, the re-
sults of these challenge studies are presented as a total
count per gram feces which represent the challenge
STEC(s). Therefore, it is impossible to determine if there
was one or more challenge or non-challenge STECs con-
tributing to the shedding rates. However, these studies do
suggest that persistent shedding or high infection can be
achieved using multiple O157 STECs [11,25]. There is also
some evidence to support strain origin or virulence traits
as contributing to infection and severity of disease in neo-
natal calves [13]. For example, challenging neonatal calves
with an O157 STEC (3081, pig origin) caused greater clin-
ical symptoms and pathology than O157 STEC (EDL-933,
human origin) including diarrhea, colonic edema, A/E le-
sions, diffuse neutrophil infiltration, diffuse atrophy of ilealvilli and fibrinohemorrhagic pseudomembranes. The current
study extends this information and indicates that STEC di-
versity and at least one virulence trait, Stx expression, con-
tribute to the severity of infection and subsequent shedding
by beef feeder calves.
There have been many studies examining the prevalence
and persistence of O157 or non-O157 STEC in feces of
beef feeder calves in feedlots [21,22]. Repeated isolations of
genetically distinct STECs from feedlots has suggested that
the main source for STEC transmission was the feedlot en-
vironment and not the incoming calves [12]. The current
study confirmed that about 60% of STEC infections that
result in shedding occur as a result of newly acquired
STEC infections in the feedlot. There was, however, a no-
ticeable 10% increase in the proportion of control calves
shedding O157 STEC at entry in summer compared with
spring. Unlike the non-O157 infections, the O157 STEC
infections grew and developed into co-infections with
O157 and non-O157 STECs resulting in higher shedding.
This suggests that the origin of the O157 STEC challenge
within the feedlot is critical for understanding how to
interfere with the infection process. A clue to the higher
O157 STEC shedding at entry in summer may derive from
the calves experience in the calf rearing facility. If we look
Figure 5 The effect of Shiga toxin (Stx) expression on the
amount of Shiga toxin – producing Escherichia coli (STEC) shed
by beef feeder calves fed diets containing 0 (control) or
14 g/[heifer•d] Celmanax®. The fecal samples were collected at
day 0 and again at day 35. Mean values are shown (n = 28 for both
treatments in spring; n = 30 for control treatments in summer and
n = 31 for CelmanaxTM treatments in summer). The contribution of
Stx expression was scored as follows: 1 = no Stx expression; 2 = Stx1
expression; 3 = Stx2 expression; 4 = Stx1 and Stx2 expression.
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been less than a month old in December or January and
been transported to the current feedlot in May and June
respectively. In Alberta, this time period coincides with
higher incidences of E. coli scours in calves and seasonal
increases in moldy feeds [6,7]. These factors contribute to
the development of STEC – associated JHS cases in beef
feeder calves [7] and coincide with higher prevalence of
O157 STEC in feedlot environments [26]. Therefore, early
calf exposure to STEC infections coupled with moldy feeds
or stressor events such as transport [27] could result in the
suppression of the cellular and humoral immune response
in calves [28,29] leading to chronic STEC infections which
then, could carry over to the next feedlot and account for
seasonal variation in shedding patterns by calves.
Most STECs that are associated with the development
of HUS in humans do not cause clinical symptoms or
disease in mice, but there are a few isolates with unique
virulence factors that enable the STEC to colonize the
intestine and produce mucosal damage that facilitates
the development of systemic disease [8-10]. The primary
virulence factor associated with high colonization is Stx
production in humans and mice with Stx2 production
associated with more severe clinical symptoms [1,8]. The
current study suggests that Stx promotes STEC infectionin beef feeder calves. For example, 10 times greater shed-
ding was achieved for STEC expressing Stx2 alone com-
pared with STEC expressing Stx1 or both Stx1 and Stx2.
The role of Stx1 in the STEC infection process in calves is
unclear, but it may increase infection by preventing cellu-
lar immune responses [15]. The role of Stx2 in the STEC
infection process has been examined in STEC challenge
studies with neonatal calves. STEC containing the eae and
stx2 genes achieved greater clinical symptoms and devel-
opment of disease compared with eae- or stx2- negative
strains [13]. This agrees with in vitro studies which sug-
gested that Stx2 promoted higher STEC (bovine or human
origin) colonization of the mucosa and a bovine colonic
cell line [16]. More significantly, STEC mixtures express-
ing one or more Stxs caused higher infections that led to
greater fecal shedding. The similarity between beef feeder
calf and neonatal calf responses to natural STEC chal-
lenges support the hypothesis that older calves are devel-
oping STEC infections and are not simply reservoirs.
Beef feeder calves encounter a variety of stressor events
such as extreme weather conditions during transport to and
after entry into the feedlot environment [27,29]. Such stres-
sor events are known to reduce the ability of calves to fight
pathogen infections which can lead to the development of
chronic scours [30,31]. The CelmanaxW application did pre-
vent: 1) the maintenance and acquisition of new O157 and
non-O157 STEC infections in calves; and 2) the mainten-
ance and acquisition of new STEC co-infections in spring,
but was unable to do so effectively in summer. This suggests
that the dosage was insufficient under summer feedlot con-
ditions possibly due to a greater number of stressor events
present in the feedlot environment.
Conclusions
This study conducted on beef feeder calves supports a role
for STEC diversity and Stx expression in influencing se-
verity of STEC infection and shedding by calves. In spring,
application of 14 g/[heifer•d] CelmanaxW was effective at
reducing the maintenance and acquisition of single and
mixed STEC infections in calves, but was ineffective in
summer. Further studies are required to determine the ef-
fective dosage of CelmanaxW to manage STEC shedding
in calves throughout the year.
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